Muscle aging study for childhood cancer survivors
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at muscle health and aging in adults who had childhood cancer. Researchers want to see how muscle mass and strength change over time and what factors (like past treatments) might affect this.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and enrolled in the SJLIFE study.
- Have a low muscle mass score or low grip or leg strength.
- May or may not have been exposed to a nerve-damaging treatment.
- No metal implants or devices that would interfere with an MRI.
- Not be pregnant and weigh less than 300 pounds.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses imaging to look at how well the mitochondria (the tiny power plants inside your muscle cells) are working. It compares survivors of childhood leukemia who have low muscle mass to healthy volunteers, to understand muscle health and find ways to help.
This study tests whether personalized cooking and nutrition guidance plus a physical activity program can help reduce muscle loss in people with advanced cancer. It aims to improve strength and quality of life during chemotherapy.
This study tests whether a structured exercise program can help breast cancer survivors who have lost muscle strength and mass (sarcopenia) rebuild their muscle and improve their physical function. Participation involves supervised or guided exercises designed to be safe for your condition.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
Hear when a new Muscle Weakness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.